Compound Monoammonium Glycyrrhizinate Injection

Monoammonium glycyrrhizinate has a strong affinity for liver steroid metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce gamma-IFN and interleukin II, increase NK cell activity and OKT1/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, reduce cell damage and necrosis; promote epithelial cells to produce mucopolysaccharides. Cysteine hydrochloride can be converted into methionine in the body. It is an essential amino acid that can synthesize choline and creatine in the human body. Choline is an anti-fatty liver substance that has therapeutic and liver-protective effects on toxic hepatitis caused by arsenic, barbiturates, carbon tetrachloride and other organic substances, and methionine.

This product is a compound preparation, and its components are: each 1 ml contains 1.8-2.2 mg of monoammonium glycyrrhizinate (C42H65NO16?2H2O), 1.45-1.75 mg of L-cysteine hydrochloride (C3H7NO2S?HCl?H2O), and 18.0-22.0 mg of aminoacetic acid (C2H5NO2).

This product is a colorless clear liquid.

It is used for abnormal liver function caused by acute, chronic and persistent hepatitis; it has a certain auxiliary therapeutic effect on toxic hepatitis, traumatic hepatitis and cancer. It can also be used for food poisoning, drug poisoning, drug allergy, etc.

Intravenous drip: 20-80ml at a time, add 5% glucose or 0.9% sodium chloride 250-500ml injection solution to dilute, and slowly drip. Once a day. Intravenous push: 20-80ml at a time, add an equal amount of 5% glucose injection solution, and slowly push intravenously. Once a day. Intramuscular or subcutaneous injection: 2-4ml at a time, 2ml for children at a time or follow the doctor's advice. 1-2 times a day.

Poor appetite, nausea, vomiting, abdominal distension, itchy skin, urticaria, dry mouth and edema; common cardiovascular and cerebrovascular system symptoms include headache, dizziness, palpitations and increased blood pressure. The above symptoms are generally mild and do not affect treatment.

1. Patients who are allergic to this product are prohibited from using this product. 2. Patients with severe hypokalemia and hypernatremia are prohibited from using this product. 3. Patients with hypertension and heart failure are prohibited from using this product. 4. Patients with renal failure are prohibited from using this product.

Not yet clear.

Keep tightly closed in a cool, dark place.

20ml

Chengdu Brilliant Pharmaceutical Co., Ltd.

• Founded in:

  1995-10-10

• Address:

  No. 263, Hexiang 3rd Street, Chengdu Hi-tech Zone

• Tax NO.:

  91510100633104205M

• Registered Funds:

  450 million yuan

• Website:

  Log in to view

• Email:

  Log in to view